Liver steatosis adverse outcome pathway (Homo sapiens)
From WikiPathways
Description
Liver steatosis refers to lipid accumulation in hepatocytes, caused either by over-nutrition, visceral obesity, metabolic syndrome, or environmental toxins. Liver steatosis can be divided into three main categories: alcoholic liver disease (ALD), non-alcoholic liver disease (NAFLD), and toxicant-associated liver disease (TAFLD). Review on liver steatosis
Quality Tags
Ontology Terms
Bibliography
View all... |
- Quattrochi LC, Vu T, Tukey RH; ''The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction.''; J Biol Chem, 1994 PubMed Europe PMC Scholia
- Shimada T, Oda Y, Gillam EM, Guengerich FP, Inoue K; ''Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.''; Drug Metab Dispos, 2001 PubMed Europe PMC Scholia
- Kolluri SK, Weiss C, Koff A, Göttlicher M; ''p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells.''; Genes Dev, 1999 PubMed Europe PMC Scholia
- Hariparsad N, Chu X, Yabut J, Labhart P, Hartley DP, Dai X, Evers R; ''Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes.''; Nucleic Acids Res, 2009 PubMed Europe PMC Scholia
- Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT; ''Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes.''; J Biol Chem, 2003 PubMed Europe PMC Scholia
- Handschin C, Meyer UA; ''Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR.''; Arch Biochem Biophys, 2005 PubMed Europe PMC Scholia
- Pavek P, Dvorak Z; ''Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues.''; Curr Drug Metab, 2008 PubMed Europe PMC Scholia
- Hashimoto K, Mori M; ''Crosstalk of thyroid hormone receptor and liver X receptor in lipid metabolism and beyond [Review].''; Endocr J, 2011 PubMed Europe PMC Scholia
- Bock KW; ''From differential induction of UDP-glucuronosyltransferases in rat liver to characterization of responsible ligand-activated transcription factors, and their multilevel crosstalk in humans.''; Biochem Pharmacol, 2011 PubMed Europe PMC Scholia
- Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C; ''Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.''; Diabetes, 2006 PubMed Europe PMC Scholia
- Nebert DW, Petersen DD, Puga A; ''Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin.''; Pharmacogenetics, 1991 PubMed Europe PMC Scholia
- Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, Sutter TR, Greenlee WF; ''Isolation and characterization of the human cytochrome P450 CYP1B1 gene.''; J Biol Chem, 1996 PubMed Europe PMC Scholia
- Mellor CL, Steinmetz FP, Cronin MT; ''The identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome pathways.''; Crit Rev Toxicol, 2016 PubMed Europe PMC Scholia
- Kodama S; ''Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes''; Mol Cell Biol, 2004 PubMed Europe PMC Scholia
- Handschin C, Meyer UA; ''Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR.''; Arch Biochem Biophys, 2005 PubMed Europe PMC Scholia
- Sugatani J, Kojima H, Ueda A, Kakizaki S, Yoshinari K, Gong QH, Owens IS, Negishi M, Sueyoshi T; ''The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR.''; Hepatology, 2001 PubMed Europe PMC Scholia
- Echchgadda I, Song CS, Oh T, Ahmed M, De La Cruz IJ, Chatterjee B; ''The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4alpha in the regulation of human steroid-/bile acid-sulfotransferase.''; Mol Endocrinol, 2007 PubMed Europe PMC Scholia
- Brigitte Landesmann, Marina Goumenou, Sharon Munn, Maurice Whelan; ''Description of Prototype Modes-of-Action Related to Repeated Dose Toxicity ''; http://publications.jrc.ec.europa.eu/repository/bitstream/JRC75689/lb-na-25631-en-n.pdf, 2012
- Maglich JM, Watson J, McMillen PJ, Goodwin B, Willson TM, Moore JT; ''The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction.''; J Biol Chem, 2004 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
AMP-activated Protein Kinase (AMPK) Signaling | Pathway | WP1403 (WikiPathways) | |
Angiopoietin Like Protein 8 Regulatory Pathway | Pathway | WP3915 (WikiPathways) | |
Aryl Hydrocarbon Receptor Netpath | Pathway | WP2586 (WikiPathways) | |
Branched-chain amino acid catabolism | Pathway | WP3556 (WikiPathways) | |
Cholesterol metabolism | Pathway | WP4718 (WikiPathways) | |
Constitutive Androstane Receptor Pathway | Pathway | WP2875 (WikiPathways) | |
Cytoplasm displacement | Key Event | ||
Endoplasmic reticulum stress | |||
Fatty Acid Biosynthesis | Pathway | WP357 (WikiPathways) | |
Fatty liver cells | Key Event | ||
KE10106: Fatty Acid Lysis | Key Event | 10106 (AOP-Wiki KE) | |
KE115: Increase, FA Influx | Key Event | 115 (AOP-Wiki KE) | |
KE116: Activation, FAS | Key Event | 116 (AOP-Wiki KE) | |
KE1214: Altered gene expression specific to CAR activation, Hepatocytes | Key Event | 1214 (AOP-Wiki KE) | |
KE140: Decreased, HSD17B10 expression | Key Event | 140 (AOP-Wiki KE) | |
KE167: Activation, LXR | Key Event | 167 (AOP-Wiki KE) | |
KE18: Activation, AhR | Key Event | 18 (AOP-Wiki KE) | |
KE227: Activation, PPARα | Key Event | 227 (AOP-Wiki KE) | |
KE228: PPARγ | Key Event | 228 (AOP-Wiki KE) | |
KE245: Activation, PXR/SXR | Key Event | 245 (AOP-Wiki KE) | |
KE258: Activation, SCD-1 | Key Event | 258 (AOP-Wiki KE) | |
KE264: Activation, SREBP-1c | Key Event | 264 (AOP-Wiki KE) | |
KE291: Accumulation, Triglyceride | Key Event | 291 (AOP-Wiki KE) | |
KE345: Liver steatosis | Key Event | 345 (AOP-Wiki KE) | |
KE466: Up Regulation, LDLR (low density lipoprotein receptor) | Key Event | 466 (AOP-Wiki KE) | |
KE471: Inhibition, FoxA2 | Key Event | 471 (AOP-Wiki KE) | |
KE472: Down Regulation, CPT1A | Key Event | 472 (AOP-Wiki KE) | |
KE474: Down Regulation, HMGCS2 | Key Event | 474 (AOP-Wiki KE) | |
KE54 Up Regulation, CD36 | Key Event | 54 (AOP-Wiki KE) | |
KE66: Activation, ChREBP | Key Event | 66 (AOP-Wiki KE) | |
KE860: Decreased, Mitochondrial Fatty Acid Beta Oxidation | Key Event | 860 (AOP-Wiki KE) | |
KE89: Synthesis, De Novo FA | Key Event | 89 (AOP-Wiki KE) | |
Lipid Metabolism Pathway | Pathway | WP3965 (WikiPathways) | |
Liver X Receptor Pathway | Pathway | WP2874 (WikiPathways) | |
Metabolic pathway of LDL | Pathway | WP4522 (WikiPathways) | |
Mitochondrial LC-Fatty Acid Beta-Oxidation | Pathway | WP357 (WikiPathways) | |
Mitochondrial disruption | Key Event | ||
Nucleus distrortion | Key Event | ||
PPAR Alpha Pathway | Pathway | WP2878 (WikiPathways) | |
PPAR signaling Pathway | Pathway | WP3942 (WikiPathways) | |
PPARδ | Key Event | ||
Pregnane X Receptor pathway | Pathway | WP2876 (WikiPathways) | |
Sterol Regulatory Element-Binding Proteins (SREBP) signalling | Pathway | WP1982 (WikiPathways) |
Annotated Interactions
No annotated interactions